{"title":"Somatic variant profiling of a thymoma in Good syndrome","authors":"Kae Takagi , Yui Namikawa , Masayuki Nagasawa , Masahiro Mae , Yoshihiko Watanabe , Kohsuke Imai , Hirokazu Kanegane , Tomohiro Morio , Masatoshi Takagi","doi":"10.1016/j.clicom.2024.02.004","DOIUrl":null,"url":null,"abstract":"<div><p>Good syndrome (GS) is a combined immunodeficiency that is associated with thymomas. The cause of the reduction in B-cells in patients with GS may be multifactorial and may include dysregulated T-cell responses. It has been proposed that tumorigenesis in a normal thymus alters thymic epithelial cell function, which leads to attenuated elimination of T-cells autoreactive to B-cells. Although the comprehensive genetic analysis of thymoma has been performed and reported in many articles, the comprehensive genetic analysis specified for GS-related thymoma has not been reported. Herein, we report comprehensive genetic analysis of a thymoma taken from a patient with GS. Oncogenesis-associated genes that may contribute to thymoma development were detected. Additionally, alteration of <em>VCAM1</em>, which is required in the interaction between T-cells and thymic epithelial cells, was observed. Aberrantly expressed VCAM1 in thymic epithelial cells may decrease the efficacy of negative of selection autoreactive T-cells and contribute to autoimmunity to B-cells.</p></div>","PeriodicalId":100269,"journal":{"name":"Clinical Immunology Communications","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772613424000039/pdfft?md5=cb5d7cc0913d4adf0ba1ae4f12b0b913&pid=1-s2.0-S2772613424000039-main.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Immunology Communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772613424000039","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Good syndrome (GS) is a combined immunodeficiency that is associated with thymomas. The cause of the reduction in B-cells in patients with GS may be multifactorial and may include dysregulated T-cell responses. It has been proposed that tumorigenesis in a normal thymus alters thymic epithelial cell function, which leads to attenuated elimination of T-cells autoreactive to B-cells. Although the comprehensive genetic analysis of thymoma has been performed and reported in many articles, the comprehensive genetic analysis specified for GS-related thymoma has not been reported. Herein, we report comprehensive genetic analysis of a thymoma taken from a patient with GS. Oncogenesis-associated genes that may contribute to thymoma development were detected. Additionally, alteration of VCAM1, which is required in the interaction between T-cells and thymic epithelial cells, was observed. Aberrantly expressed VCAM1 in thymic epithelial cells may decrease the efficacy of negative of selection autoreactive T-cells and contribute to autoimmunity to B-cells.
古德综合征(GS)是一种与胸腺瘤相关的联合免疫缺陷病。古德综合征患者 B 细胞减少的原因可能是多因素的,其中可能包括 T 细胞反应失调。有人认为,正常胸腺中的肿瘤发生改变了胸腺上皮细胞的功能,从而导致对 B 细胞有自反应的 T 细胞的清除能力减弱。虽然已有许多文章对胸腺瘤进行了全面的基因分析和报道,但专门针对 GS 相关胸腺瘤的全面基因分析尚未见报道。在此,我们报告了对一名 GS 患者胸腺瘤的全面基因分析。我们发现了可能导致胸腺瘤发生的肿瘤发生相关基因。此外,我们还观察到T细胞与胸腺上皮细胞之间相互作用所需的VCAM1发生了改变。胸腺上皮细胞中畸形表达的VCAM1可能会降低自体反应性T细胞负向选择的功效,并导致B细胞自身免疫。